• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Stroke/CVA (1770); Hematoma (1884); Myocardial Infarction (1969); Occlusion (1984); Pneumonia (2011); Renal Failure (2041); Perforation of Vessels (2135); Heart Failure (2206); Rupture (2208); Claudication (2550); Pseudoaneurysm (2605); Multiple Organ Failure (3261)
Event Date 03/12/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received the following information obtained from the journal article entitled: "midterm results with the open chimney technique during endovascular aneurysm repair." eric ducasse, caroline caradu, coline brochier, dominique midy, xavier berard, mathieu poirier, and nicolas ottaviani.Journal of vascular and interventional radiology 2019; 30: 511¿520 https://doi.Org/10.1016/j.Jvir.2018.09.013.An endurant stent graft system was implanted in 22 patients out of a group of 67, for chevar treatment.  the following adverse events were observed: malfunctions: device-to-device and device-to-vessel interaction (with re-intervention) type ia endoleaks type ib endoleak type iii endoleaks adverse events: access site hematomas femoral dissection false-aneurysms lymphoceles buttock claudication iliac limb occlusion iliac rupture pneumonia embolic stroke heart failure myocardial infarction multiple organ failure ruptured aneurysm acute kidney injury death (30-day) abstract purpose: to report the midterm experience with chimney-endovascular aneurysm repair (ch-evar) with the use of open self-expanding stents for branch vessel preservation.Materials and methods: from july 2010 to may 2017, 67 patients underwent open ch-evar because their proximal landing zones were adjacent to, or covered, the renal or mesenteric arteries (zones 7¿9), and they were not suitable for standard or fenestrated endovascular aneurysm repair.The proximal landing zone was relocated below the highest renal artery in 46 cases, the superior mesenteric artery in 17 cases, and the celiac artery in 4 cases, using 84 open chimneys (131 stents).A subgroup analysis was performed between an early (2010¿2014) and a later (2015¿2017) time period.Thirty-two patients were treated during the early period, and 35 were treated during the later period.In the later period, open chimneys were strengthened by a second self-expanding stent.Results: the primary technical success rate was 89.6%; the early mortality rate was 9.0%; and the median follow-up duration was 13 months (range, 1¿76 months).The estimated actuarial survival rate was 85.7% in year 1 and 79.2% in year 2, and the estimated patency rate of open chimneys reached 95.2% at 2 years.Aneurysm sac regression >5 mm and sac stability rates were 39.0% and 57.6%, respectively.Freedom from aneurysm-related reintervention was lower in the later period (log-rank p ¼.04), while type ia endoleaks tended to be twice as likely.Conclusions: midterm results of open ch-evar show high technical success with acceptable midterm patency and lack of endoleak in appropriately selected patients.The advantages over covered stents are lower-profile delivery systems and maintenance of branch vessel patency in early bifurcations and overlying visceral vessels.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key8594994
MDR Text Key144550486
Report Number2953200-2019-00620
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/17/2019
Initial Date FDA Received05/09/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-